centre hospitalier universitaire vaudois (CHUV)
Lausanne CH-1011
1 studies enrolling now · 32 studies all time
What they study most
Achondroplasia, Acute Decompensation of Chronic Heart Failure, Acute Heart Failure, Acute Kidney Injury, Advanced Solid Tumors, Anemia, Hemolytic, Atopic Dermatitis, Bacterial Vaginosis, Candida Vaginitis, Cardiovascular Abnormalities, Cardiovascular Diseases, Cerebral Stroke
Studies at this site
- Sonocloud-9 in Association With Carboplatin Versus Standard-of-Care Chemotherapies (CCNU or TMZ) in Recurrent GBM — Recruiting now
- A Study to Evaluate the Safety of INCA33890 in Participants With Advanced or Metastatic Solid Tumors — Recruiting now
- EF-41/KEYNOTE D58: Phase 3 Study of Optune Concomitant With Temozolomide Plus Pembrolizumab in Newly Diagnosed Glioblastoma — Recruiting now
- Weight Loss in People Living With Overweight or Obesity and Type 2 Diabetes Following Treatment With Cagrilintide — Running, not enrolling
- A Study of Selexipag as Add-On Treatment to Standard of Care in Children With Pulmonary Arterial Hypertension — Running, not enrolling
- A 2-Part Study to Learn Whether Litifilimab (BIIB059) Injections Can Improve Symptoms of Adult Participants Who Have Active Cutaneous Lupus Erythematosus — Running, not enrolling
- A Study of Milvexian in Participants After an Acute Ischemic Stroke or High-Risk Transient Ischemic Attack- LIBREXIA-STROKE — Running, not enrolling
- A Study to Evaluate ATP150/ATP152/ATP162, VSV-GP154 and Ezabenlimab in Patients With Pancreatic Ductal Adenocarcinoma — Running, not enrolling
- Study of INCB123667 in Subjects With Advanced Solid Tumors — Running, not enrolling
- Tailored Axillary Surgery With or Without Axillary Lymph Node Dissection Followed by Radiotherapy in Patients With Clinically Node-positive Breast Cancer (TAXIS) — Running, not enrolling
- 10°C vs 4°C Lung Preservation RCT — Running, not enrolling
- Advancing Cath Lab Results With FFRangio Coronary Physiology Assessment — Running, not enrolling
- A Study to Evaluate the Efficacy and Safety of Ruxolitinib Cream in Participants With Prurigo Nodularis (PN) — Completed
- A Study of INCMGA00012 in Metastatic Merkel Cell Carcinoma (POD1UM-201) — Completed
- Performance Study of the Cobas® BV/CV Test on Samples From Participants With and Without Symptoms of Bacterial Vaginosis and Candida Vaginitis — Completed
- CERENOVUS Neurothrombectomy Devices Registry — Completed
- Safety and Efficacy Study of reSept ASD Occluder for Treating Secundum ASD — Running, not enrolling
- A Study of the Effectiveness and Safety of Nivolumab Compared to Bevacizumab and of Nivolumab With or Without Ipilimumab in Glioblastoma Patients — Completed
- Standard vs. Accelerated Initiation of RRT in Acute Kidney Injury (STARRT-AKI: Principal Trial) — Completed
- Observational Study Investigating Clinical & Anthropometric Characteristics of Children With Achondroplasia. — Stopped early
- A Study to Evaluate Efficacy and Safety of AG-348 in Not Regularly Transfused Adult Participants With Pyruvate Kinase Deficiency (PKD) — Completed
- A Trial to Evaluate the Efficacy of PRM-151 in Subjects With Idiopathic Pulmonary Fibrosis (IPF) — Completed
- Phase 3 Study to Evaluate the Efficacy and Safety of Elafibranor Versus Placebo in Patients With Nonalcoholic Steatohepatitis (NASH) — Stopped early
- A Study of Crisaborole Ointment 2%; Crisaborole Vehicle; TCS and TCI in Subjects Aged ≥ 2 Years, With Mild-moderate AD — Stopped early
- Study to Determine Efficacy and Safety of Lenalidomide Plus Low-dose Dexamethasone Versus Melphalan, Prednisone, Thalidomide in Patients With Previously Untreated Multiple Myeloma — Completed
- The PROOF Study: The PICC Related Obstruction Of Flow Study — Stopped early
- Tezosentan in Acute Heart Failure — Completed
- Tezosentan in Pulmonary Arterial Hypertension — Stopped early
- Dose Ranging Study of RPC4046 in Eosinophilic Esophagitis — Completed
- Effect of NovoTTF-100A Together With Temozolomide in Newly Diagnosed Glioblastoma Multiforme (GBM) — Completed
- MDX-010 Antibody, MDX-1379 Melanoma Vaccine, or MDX-010/MDX-1379 Combination Treatment for Patients With Unresectable or Metastatic Melanoma — Completed
- A Comparison of Two Ways to Manage Anti-HIV Treatment (The SMART Study) — Completed